Recombinant Human Melanoma antigen preferentially expressed in tumors (PRAME)

Recombinant Human Melanoma antigen preferentially expressed in tumors (PRAME) is a purified Recombinant Protein. Purity: >90% as determined by SDS-PAGE. Host: E. coli. Endotoxin Level: Not Tested. Species: Human (Homo sapiens). Target Name: PRAME. Target Synonyms: Opa-interacting protein 4; OIP-4Preferentially expressed antigen of melanoma. Accession Number: P78395. Expression Region: 1~509aa. Tag Info: N-Terminal 6Xhis-Tagged. Theoretical MW: 61.9kDa. Buffer: If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.